Evidence map›Paper›PMID 35894186›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2022

[Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases].

Ping-Ping Zhang, Yan-Ting Guo, Yu-Qin Chu, Q I Ji, Yan Lian, Wei Li, Li-Na Yao

Open access · greenAbstract read
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ping-Ping ZhangDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Yan-Ting GuoDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Yu-Qin ChuDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Q I JiDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Yan LianDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Wei LiDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Li-Na YaoDepartment of Pediatrics, Tianjin First Central Hospital, Tianjin 300190, China.
Tianjin First Center Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the serum level of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific RBD IgG antibody (SARS-CoV-2 IgG antibody for short) in children with SARS-CoV-2 Omicron variant infection during the recovery stage, as well as the protective effect of SARS-CoV-2 vaccination against Omicron infection.

methodsA retrospective analysis was performed on 110 children who were diagnosed with coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 Omicron variant infection in Tianjin of China from January 8 to February 7, 2022. According to the status of vaccination before diagnosis, they were divided into a booster vaccination (3 doses) group with 2 children, a complete vaccination (2 doses) group with 90 children, an incomplete vaccination (1 dose) group with 5 children, and a non-vaccination group with 13 children. The clinical data and IgG level were compared among the 4 groups.

resultsThe complete vaccination group had a significantly higher age than the non-vaccination group at diagnosis (

conclusionsVaccination with inactivated SARS-CoV-2 vaccine has a protective effect against Omicron infection in children. For children vaccinated with 2 doses of the vaccine who experience Omicron infection, there may be a slight reduction in the level of SARS-CoV-2 IgG antibody at 2 months after diagnosis.

Indexed as

COVID-19Viral VaccinesAntibodies, ViralChildCOVID-19 VaccinesHumansImmunoglobulin GRetrospective StudiesSARS-CoV-2Antibodies, ViralCOVID-19 VaccinesImmunoglobulin GViral VaccinesChildCoronavirus disease 2019IgGOmicronRecovery stageVaccination

Identifiers

PMID35894186
PMCPMC9336630
OpenAlexW4288192957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.